Immunic Stock Price - IMUX

6.59
0.09 (1.38%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.41 6.73% 6.50 6.0213 7.00 6.09 6.09 20:00:00
Bid Price Ask Price Spread Spread % News
4.50 9.94 5.44 54.73% 2 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
270 25,460 $ 6.45 $ 164,194 26,648 4.19 - 22.6626
Last Trade Time Type Quantity Stock Price Currency
16:00:00 8 $ 6.59 USD

Immunic Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 69.84M 10.74M $ -41.48M -11.70 - 10.41M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 1.00 3.10%

more financials information »

Immunic News

Date Time Source News Article
4/09/202010:34Edgar (US Regulatory)Other Filing
4/09/202010:34Edgar (US Regulatory)Other Filing
3/23/202010:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/16/202016:09Edgar (US Regulatory)Annual Report (10-k)
3/16/202016:09Edgar (US Regulatory)Current Report Filing (8-k)
3/16/202016:01PR Newswire (US)Immunic, Inc. Reports Year End 2019 Financial Results and..
2/11/202006:30PR Newswire (US)Immunic, Inc. to Participate in Scientific and Investor..

Latest IMUX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.577.205.286.3825,0660.9316.7%
1 Month7.0010.004.196.6144,748-0.50-7.14%
3 Months9.4910.004.197.4026,417-2.99-31.51%
6 Months9.5510.004.197.9627,940-3.05-31.94%
1 Year22.0022.66264.1912.6368,378-15.50-70.45%
3 Years22.0022.66264.1912.6368,378-15.50-70.45%
5 Years22.0022.66264.1912.6368,378-15.50-70.45%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.
Your Recent History
NASDAQ
IMUX
Immunic
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200410 06:57:43